References
- Chau JK, Lin JR, Atashband S, et al. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope. 2010;120:1011–1021.
- Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008;359:833–840.
- Xue Han Y, Yin X, Du X, et al. Combined intratympanic and systemic use of steroids as a first-line treatment for sudden sensorineural hearing loss: a meta-analysis of randomized, controlled trials. Otol Neurotol. 2017;38:487–495.
- Chen CH, Young YH. N-acetylcysteine as a single therapy for sudden deafness. Acta Otolaryngol. 2017;137:58–62.
- Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106:772–776.
- Wu HP, Chou YF, Yu SH, et al. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol. 2011;32:774–779.
- Bae SC, Noh HI, Jun BC, et al. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Acta Otolaryngol. 2013;133:428–433.
- Edizer DT, Çelebi Ö, Hamit B, et al. Recovery of idiopathic sudden sensorineural hearing loss. J Int Adv Otol. 2015;11:122–126.
- Ho HG, Lin HC, Shu MT, et al. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope. 2004;114:1184–1189.
- Yang HC, Cho YB, Jang CH, et al. Efficacy of concomitant intratympanic steroid injection for sudden deafness according to initial hearing loss. Otol Neurotol. 2015;36:1604–1609.
- Lee JD, Park MK, Lee CK, et al. Intratympanic steroids in severe to profound sudden sensorineural hearing loss as salvage treatment. Clin Exp Otorhinolaryngol. 2010;3:122–125.
- Gundogan O, Pinar E, Imre A, et al. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngol Head Neck Surg. 2013;149:753–758.
- Ahn JH, Yoo MH, Yoon TH, et al. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope. 2008;118:279–282.
- Arslan N, Oğuz H, Demirci M, et al. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2011;32:393–397.
- Labatut T, Daza MJ, Alonso A. Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature. Eur Arch Otorhinolaryngol. 2013;270:2823–2832.
- Suzuki H, Mori T, Hashida K, et al. Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2011;268:497–500.
- Lee JB, Choi SJ. Potential benefits of combination therapy as primary treatment for sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2016;154:328–334.
- Hargunani CA, Kempton JB, DeGagne JM, et al. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol. 2006;27:564–569.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1–17.
- Belhassen S, Saliba I. Pain assessment of the intratympanic injections: a prospective comparative study. Eur Arch Otorhinolaryngol. 2012;269:2467–2473.